Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,431 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07755423 | Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical Study | enrolling by invitation | — | 44 | Fudan UniversityOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07713901 | Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma | enrolling by invitation | — | 93,600,000 | Novo Nordisk A/SINDUSTRY | 1 | Aug 4, 2026 |
| NCT07234539 | Evaluation of an Artificial Intelligence-enabled Clinical Assistant to Support Thyroid Cancer Management | enrolling by invitation | N/A | 76 | The University of Hong KongOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07532928 | A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data | enrolling by invitation | — | 571 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT07682883 | The Importance of Mucosal Screening in the Prevention of Oral Cancer. | enrolling by invitation | N/A | 1,383 | Medical University of WarsawOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT07618624 | BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression(BRIDGE) | enrolling by invitation | Phase 2 | 42 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT07606638 | Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients | enrolling by invitation | N/A | 98 | Mayo Hospital LahoreOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07603167 | p-PHOTOLARYNX- ANTHEM: Photon-Counting CT in Laryngeal Cancer Staging(H&NRAD-2025-01) | enrolling by invitation | — | 60 | Humanitas UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06885424 | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products(DESCENT-1) | enrolling by invitation | — | 400 | A2 Biotherapeutics Inc.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT07550972 | Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib. | enrolling by invitation | Phase 2 | 30 | Zhejiang Provincial People's HospitalOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07057284 | DENTOFACIAL-PBT Stage 2 - Feasibility Study | enrolling by invitation | — | 255 | Manchester University NHS Foundation TrustOTHER_GOV | 1 | Jan 26, 2026 | clinicaltrials |
| NCT07363031 | Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy | enrolling by invitation | Phase 2 | 84 | Instituto OncoclinicasOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07072676 | The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.(Risk of fall) | enrolling by invitation | N/A | 30 | LMU KlinikumOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07051265 | Effect of Transcutaneous Electrical Nerve Stimulation or Acupressure on Pain in Patients With Head and Neck Cancer | enrolling by invitation | N/A | 240 | Kaohsiung Veterans General Hospital.OTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT06261190 | Active Surveillance for Low-risk Papillary Thyroid Carcinoma(MAeSTro-EXP) | enrolling by invitation | — | 499 | National Cancer Center, KoreaOTHER_GOV | 1 | May 11, 2025 | clinicaltrials |
| NCT06690216 | Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors(PD-L1-PET) | enrolling by invitation | Phase 1 / Phase 2 | 100 | Man HuOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06852144 | PET-TC in Thyroid Evaluation(PEPATI-MN-2024) | enrolling by invitation | — | 418 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06809673 | PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial | enrolling by invitation | — | 400 | Ospedale Policlinico San MartinoOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06763640 | Prognostic Value of TIL in Nasopharyngeal Carcinoma | enrolling by invitation | — | 216 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT06672471 | Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial(PEACH) | enrolling by invitation | N/A | 170 | Shaukat Khanum Memorial Cancer Hospital & Research CentreOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT05376553 | Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck | enrolling by invitation | Phase 1 | 24 | Krzysztof MisiukiewiczOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT06583395 | Quest to Analyze One Thousand Humans Meditating(QUANTUM) | enrolling by invitation | — | 3,000 | Tobias Moeller-BertramINDUSTRY | 1 | Nov 1, 2024 | clinicaltrials |
| NCT01511393 | An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | enrolling by invitation | — | 6,750 | Novo Nordisk A/SINDUSTRY | 1 | Jun 13, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Aug 10, 2026source: clinicaltrials